We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

Here are 2 very different penny stocks. Should I buy them?

Our writer looks at two penny stocks with different characteristics. But when it comes to deciding which to buy, he arrives at the same conclusion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

British Pennies on a Pound Note

Image source: Getty Images

There are two penny stocks I’ve been researching at opposite ends of the innovation spectrum.

One is a relatively new company at the cutting edge of international medical research. The other has been in business for 60 years, selling tiles from its large chain of UK stores.

However, each has recently caught my eye due to significant movements in their share prices.

Should I buy one, both, or neither of them?

An innovative approach

Shares in Angle (LSE:AGL) have increased 64% since the start of 2024.

The announcement of a “breakthrough” in trials for its cancer diagnostics tool have helped propel them higher.

In 70% of patients, the company’s technology found cancer mutations in cells that could not be identified from the DNA in the same blood.

There’s little point dwelling on the financial performance of the company as the investment case is built entirely around its future potential.

By 30 June 2023, the company had accumulated losses of £113m. Yet revenue for 2023 is expected to be only £2.2m.

On the plus side, it says it has sufficient cash to see it through until, at least, the first quarter of 2025.

Old-fashioned

By contrast, Topps Tiles (LSE:TPT) stock is down 8%, since 1 January.

Investors didn’t like the trading update that revealed sales for the 13 weeks to 30 December 2023, were 4% lower than a year earlier.

But the company has been growing steadily for several years.

It achieved its 2025 target of a 20% market share two years earlier than planned. It expects this to increase further in 2024.

And its shares are presently yielding a very attractive 7.9%. Each year, it plans to return 67% of earnings to shareholders.

However, rising costs caused its gross margin to fall from 54.8% during its 2022 financial year, to 53%, in 2023. This is something to keep an eye on.

Decision time

Although there are reasons to invest in both, I’m cautious about penny stocks.

For example, I don’t have sufficient expertise to know whether the products of innovative companies, like Angle, are going to be successful.

Its technical reports make for heavy reading.

And if I’m honest, I’d only be buying its shares on a ‘hunch’. That doesn’t feel like a sensible basis for making sound investment decisions.

Also, because what they’re doing is pushing boundaries, the timescales for bringing products to market can slip.

Ironically, with more ‘traditional’ businesses like Topps Tiles, it’s the lack of technological innovation that worries me.

‘Bricks and mortar’ retailing is tough, with the internet radically changing the way people shop.

And consumer tastes can change quickly. I’m not sure the company has the financial strength to cope with a sustained downturn.

Both Angle and Topps Tiles highlight my principal fear about penny stocks, namely, that they will run out of money. With small businesses, there’s an increased risk that any investment I make today will be diluted in the future.

Should either company need to raise funds, they will probably ask their shareholders to buy more shares, rather than increase their borrowings.

If I don’t want to participate in a rights issue, the value of my shareholding will fall. Joining in will require more cash.

As a risk-averse investor, I don’t want to have to face this dilemma.

James Beard has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

How much is £7,620 saved in a Cash ISA a decade ago worth today?

Cash ISA savers have received an average of 4% over the last decade, but Harvey Jones says the average Stocks…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

702 shares in this FTSE 100 stalwart earn a £100 a month second income

Unilever shares come with an unusually high dividend yield. Should investors looking for a second income grab the opportunity with…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

This surging FTSE 100 share just hit £201! Will it ever split its stock? 

This high-quality FTSE 100 stock is up by a staggering 4,050% in the past 10 years. Why hasn't it split…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Just over £13 after its Q1 results, here’s why HSBC shares still look a bargain-basement buy for me anywhere below £20.68

HSBC shares have surged, but fresh results hint the market may still be missing a major value opportunity that long…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

GSK’s share price is down 18% despite another set of strong results! Time for me to buy more for under £19 while I can?

GSK’s share price has fallen far below what its earnings strength implies, creating a huge price-valuation gap long-term investors won't…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

A 6.7% forecast yield and 53% under ‘fair value’! 1 FTSE income share to buy today?

This FTSE income share looks deeply undervalued despite its high payouts and cash flows, creating a rare opportunity that yield…

Read more »

Close-up of British bank notes
Investing Articles

Here’s how I’m targeting £11,363 in yearly second income from £20,000 in Aberdeen shares!

Aberdeen shares have delivered consistently high yields for years, which, when compounded, could turn a £20k investment into very high…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Here’s how investors could make £1,654 a month in retirement from just £20,000 in Standard Life shares

Passive income seekers might overlook Standard Life shares, whose dividend machine is accelerating fast. The long-term payout maths is startling.

Read more »